{"symbol": "IFRX", "companyName": "InflaRx N.V.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.inflarx.com", "description": "InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.", "CEO": "Niels Riedemann", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}